AllSquare Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $190K | Hold |
1,479
| – | – | 0.1% | 115 |
|
|
2025
Q2 | $179K | Hold |
1,479
| – | – | 0.1% | 115 |
|
|
2025
Q1 | $165K | Hold |
1,479
| – | – | 0.1% | 118 |
|
|
2024
Q4 | $144K | Hold |
1,479
| – | – | 0.08% | 125 |
|
|
2024
Q3 | $170K | Hold |
1,479
| – | – | 0.1% | 119 |
|
|
2024
Q2 | $157K | Hold |
1,479
| – | – | 0.09% | 118 |
|
|
2024
Q1 | $143K | Hold |
1,479
| – | – | 0.08% | 127 |
|
|
2023
Q4 | $149K | Hold |
1,479
| – | – | 0.09% | 118 |
|
|
2023
Q3 | $151K | Hold |
1,479
| – | – | 0.1% | 113 |
|
|
2023
Q2 | $143K | Hold |
1,479
| – | – | 0.09% | 116 |
|
|
2023
Q1 | $136K | Hold |
1,479
| – | – | 0.09% | 121 |
|
|
2022
Q4 | $134K | Hold |
1,479
| – | – | 0.09% | 114 |
|
|
2022
Q3 | $112K | Hold |
1,479
| – | – | 0.08% | 119 |
|
|
2022
Q2 | $125K | Hold |
1,479
| – | – | 0.09% | 115 |
|
|
2022
Q1 | $130K | Hold |
1,479
| – | – | 0.08% | 123 |
|
|
2021
Q4 | $129K | Hold |
1,479
| – | – | 0.08% | 125 |
|
|
2021
Q3 | $121K | Sell |
1,479
-100
| -6% | -$9K | 0.07% | 124 |
|
|
2021
Q2 | $144K | Sell |
1,579
-304
| -16% | -$27.1K | 0.08% | 125 |
|
|
2021
Q1 | $161K | Hold |
1,883
| – | – | 0.1% | 113 |
|
|
2020
Q4 | $178K | Hold |
1,883
| – | – | 0.12% | 93 |
|
|
2020
Q3 | $164K | Buy |
1,883
+226
| +14% | +$19.6K | 0.12% | 90 |
|
|
2020
Q2 | $145K | Buy |
1,657
+178
| +12% | +$15.4K | 0.11% | 95 |
|
|
2020
Q1 | $122K | Hold |
1,479
| – | – | 0.11% | 97 |
|
|
2019
Q4 | $140K | Hold |
1,479
| – | – | 0.1% | 106 |
|
|
2019
Q3 | $129K | Hold |
1,479
| – | – | 0.1% | 106 |
|
|
2019
Q2 | $135K | Sell |
1,479
-172
| -10% | -$14.6K | 0.1% | 99 |
|
|
2019
Q1 | $142K | Hold |
1,651
| – | – | 0.11% | 97 |
|
|
2018
Q4 | $127K | Hold |
1,651
| – | – | 0.11% | 94 |
|
|
2018
Q3 | $127K | Hold |
1,651
| – | – | 0.09% | 104 |
|
|
2018
Q2 | $112K | Buy |
+1,651
| New | +$114K | 0.08% | 113 |
|
|
2017
Q1 | – | Sell |
-143
| Closed | -$9K | – | 393 |
|
|
2016
Q4 | $9K | Hold |
143
| – | – | 0.01% | 239 |
|
|
2016
Q3 | $10K | Hold |
143
| – | – | 0.01% | 219 |
|
|
2016
Q2 | $11K | Sell |
143
-86
| -38% | -$5.94K | 0.01% | 205 |
|
|
2016
Q1 | $15K | Hold |
229
| – | – | 0.01% | 187 |
|
|
2015
Q4 | $18K | Buy |
229
+4
| +2% | +$318 | 0.02% | 180 |
|
|
2015
Q3 | $19K | Buy |
225
+23
| +11% | +$2.05K | 0.02% | 173 |
|
|
2015
Q2 | $18K | Buy |
202
+80
| +66% | +$7.34K | 0.02% | 184 |
|
|
2015
Q1 | $11K | Hold |
122
| – | – | 0.01% | 223 |
|
|
2014
Q4 | $10K | Buy |
+122
| New | +$10.1K | 0.01% | 227 |
|
Other funds holding NVS
AllSquare Wealth Management's NVS Position: Q3 2025 in Review
AllSquare Wealth Management held its Novartis (NVS) position steady in Q3 2025 at 1,479 shares worth $190K. The position accounts for 0.1% of the portfolio, ranked #115.
AllSquare Wealth Management first reported a position in NVS in Q4 2014 and has held it in 39 quarters since. 1,400 funds tracked by Wall St. Rank hold NVS as of Q3 2025.
- AllSquare Wealth Management held 1,479 shares of Novartis worth $190K as of Q3 2025.
- AllSquare Wealth Management left its Novartis share count unchanged in Q3 2025.
- Novartis made up 0.1% of AllSquare Wealth Management's portfolio in Q3 2025, its #115 holding.
- AllSquare Wealth Management first reported a position in Novartis in Q4 2014 and has held it in 39 quarters since.
- 1,400 funds tracked by Wall St. Rank held Novartis as of Q3 2025.
Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.